Lyka Labs vs Peers
- Market cap
- ₹264 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹53.29 – ₹99.91
Lyka Labs ranks 1st by market capitalisation among 1 Biotechnology companies tracked by ATS. Its largest peers are Lyka Labs. Its P/E of 22.5 compares with a peer median of 22.5.
Lyka Labs vs Biotechnology peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Lyka Labs | 74.01 | -0.39% | 264 | 22.5 | 2.85 | 14.5% | +18.5% |
| Lyka Labs | 74.01 | -0.39% | 264 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Lyka Labs peer comparison — frequently asked questions
Who are Lyka Labs' competitors?
Lyka Labs' listed peers in Biotechnology include Lyka Labs, ranked here by market capitalisation.
How does Lyka Labs' P/E compare with its peers?
Lyka Labs trades at a P/E of 22.5, against a median of 22.5 across the 1 Biotechnology peers shown.
Which is the largest company among Lyka Labs' peers?
By market capitalisation, the largest company in the group is Lyka Labs at ₹264 crore, against ₹264 crore for Lyka Labs.
Same Data For Peers
Trade Lyka Labs With ATS
Track LYKALABS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.